company background image
TELA logo

TELA Bio NasdaqGM:TELA Stock Report

Last Price

US$2.89

Market Cap

US$115.8m

7D

-4.6%

1Y

-48.2%

Updated

04 Dec, 2024

Data

Company Financials +

TELA Stock Overview

A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. More details

TELA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance0/6
Financial Health2/6
Dividends0/6

TELA Bio, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for TELA Bio
Historical stock prices
Current Share PriceUS$2.89
52 Week HighUS$7.84
52 Week LowUS$2.30
Beta1.0
11 Month Change1.40%
3 Month Change3.96%
1 Year Change-48.21%
33 Year Change-76.88%
5 Year Change-75.53%
Change since IPO-78.35%

Recent News & Updates

Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely

Nov 09
Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely

Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 33%

Aug 19
Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 33%

Recent updates

Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely

Nov 09
Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely

Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 33%

Aug 19
Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 33%

Does TELA Bio (NASDAQ:TELA) Have A Healthy Balance Sheet?

Jul 03
Does TELA Bio (NASDAQ:TELA) Have A Healthy Balance Sheet?

Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

May 29
Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

TELA Bio, Inc. (NASDAQ:TELA) Soars 31% But It's A Story Of Risk Vs Reward

May 23
TELA Bio, Inc. (NASDAQ:TELA) Soars 31% But It's A Story Of Risk Vs Reward

Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 24
Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Many Still Looking Away From TELA Bio, Inc. (NASDAQ:TELA)

Mar 08
Many Still Looking Away From TELA Bio, Inc. (NASDAQ:TELA)

TELA Bio (NASDAQ:TELA) Has Debt But No Earnings; Should You Worry?

Oct 07
TELA Bio (NASDAQ:TELA) Has Debt But No Earnings; Should You Worry?

Getting In Cheap On TELA Bio, Inc. (NASDAQ:TELA) Might Be Difficult

Jul 31
Getting In Cheap On TELA Bio, Inc. (NASDAQ:TELA) Might Be Difficult

TELA Bio: Tailwinds In Hernia Repair Market And Promising Clinical Data To Drive Accelerating Adoption

Oct 02

Tela Bio prices $32M common stock offering

Aug 16

Is TELA Bio (NASDAQ:TELA) Using Debt Sensibly?

May 12
Is TELA Bio (NASDAQ:TELA) Using Debt Sensibly?

TELA Bio - Follow Up With Management

Jan 14

Our First Look At TELA Bio

Nov 04

TELA Bio Plugging Away

Oct 25

TELA Bio (TELA) Investor Presentation - Slideshow

May 26

Shareholder Returns

TELAUS Medical EquipmentUS Market
7D-4.6%-0.03%0.4%
1Y-48.2%21.3%32.3%

Return vs Industry: TELA underperformed the US Medical Equipment industry which returned 21.3% over the past year.

Return vs Market: TELA underperformed the US Market which returned 32.3% over the past year.

Price Volatility

Is TELA's price volatile compared to industry and market?
TELA volatility
TELA Average Weekly Movement7.8%
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.3%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market3.1%

Stable Share Price: TELA has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: TELA's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012227Antony Koblishwww.telabio.com

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States.

TELA Bio, Inc. Fundamentals Summary

How do TELA Bio's earnings and revenue compare to its market cap?
TELA fundamental statistics
Market capUS$115.80m
Earnings (TTM)-US$41.52m
Revenue (TTM)US$68.65m

1.7x

P/S Ratio

-2.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TELA income statement (TTM)
RevenueUS$68.65m
Cost of RevenueUS$21.38m
Gross ProfitUS$47.27m
Other ExpensesUS$88.79m
Earnings-US$41.52m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.05
Gross Margin68.86%
Net Profit Margin-60.49%
Debt/Equity Ratio-653.2%

How did TELA perform over the long term?

See historical performance and comparison